1 / 24

E URO pean network of transnational collaborative RTD projects in the field of NANOMED icine

E URO pean network of transnational collaborative RTD projects in the field of NANOMED icine. What are the societal needs? - the challenge for Europe. Improve public health and welfare Ageing population Efficiency of current medical solutions

dustin
Download Presentation

E URO pean network of transnational collaborative RTD projects in the field of NANOMED icine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EUROpean network of transnational collaborative RTD projects in the field of NANOMEDicine www.euronanomed.net

  2. What are the societal needs? - the challenge for Europe Improve public health and welfare • Ageing population • Efficiency of current medical solutions • Emergence of new disease and old diseases are back • Personalized medicine future directions www.euronanomed.net

  3. The global challenge • Therapeutic solutions for only 1/3 known diseases (WHO) • Infections: HIV, TB, malaria, risk of pandemia • Need to increase capability and innovation of medical industry • Rapid and accurate diagnosis for early detection, even prevention • Novel, more efficient therapies with less side effects www.euronanomed.net

  4. Nano from research to patient and industry Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare Bridging the gap Foto: kaibara87/www.flickr.com www.euronanomed.net

  5. Emerging nanomedicine Lancet Infectious Diseases April issue, vol 9, 2009 www.euronanomed.net

  6. ES G UK F DE CP With ERA-Net CP CP CP Prog F Prog G Prog UK Prog ES Prog DE CP … Without ERA-Net Common transnational dedicated CP Principle of theERA-net scheme (CP: Call for projects) € : EC supports the coordination costs. Each national programme supports their national partners within the selected projects www.euronanomed.net

  7. EuroNanoMed covers 3/4 of European nanomedicine actors • 24 partners from 18 countries/regions • Coordination of funding programmes in nanomedicine • Started January 2009 • EU funding for coordination (ERA-net in FP7) 2 common joint calls for proposals 2009, 2010 www.euronanomed.net

  8. EuroNanoMed: an asset to bridge the gap 2 calls to support RTD projects aiming at • solving an unmet medical need using nanomedicine • promoting a multidisciplinary translational approach with an international focus EuroNanoMed will achieve a critical mass of actors !!! www.euronanomed.net

  9. EuroNanoMed outputs • Develop innovative diagnostic and therapeutic solutions for the patient, enhancing the competitiveness of the European health industry • Maturation of the field To bring together • academic teams • clinical/public health teams • industrial research teams • Cross-border collaboration between the best researchers/teams in nanomedicine www.euronanomed.net

  10. Why now? What’s the urgency? • Health industry: a key for future growth • European countries invest substantially in nano industry and basic nano research • Nano technologies: a promising field for innovation and patient application Despite these efforts, Europe is lagging behind the US in an increasing competition : Europe needs to act now! www.euronanomed.net

  11. Expected outcome • To move innovation from knowledge to industrial technology and health care applications • Opening the national programmes to support transnational RTD partnerships Long term vision: formula for an European-wide integrated programme with a coordinated funding www.euronanomed.net

  12. Contacts • Coordinator and Executive Board Chair Dr. Pierre-Noël LIRSAC Commissariat à l’Energie Atomique (CEA) Pierre-noel.lirsac@cea.fr, Virginie.sivan@cea.fr  (+33) 1 69 08 87 99 • Network Steering Committee chair Associate Prof. Karin Forsberg-Nilsson Swedish research Council (SRC) Karin.forsberg.nilsson@vr.se www.euronanomed.net

  13. EuroNanoMed ERA Networking towards ERA! www.euronanomed.net

  14. EuroNanoMed First joint transnational call for proposals 18 partners 16 countries/regions www.euronanomed.net

  15. Funding organisations in the first call for proposals • Industry, Trade and Tourism Department, Basque Government (ITT), Basque region (Spain) • Swiss National Science Foundation (SNSF), Switzerland • VDI Technologiezentrum GmbH, Germany • Instituto de Salud Carlos III (ISCIII), Spain • The French National Research Agency (ANR), France • The Chief Scientist Office, The Ministry of Health (CSO-MOH), Israel • The Icelandic Centre for Research (RANNIS), Iceland • The Latvian Academy of Sciences (LAS), Latvia • SenterNovem, The Netherlands • National Centre for Research and Development (NCBiR), Poland • Fundacao para a Ciencia e a Tecnologia (FCT), Portugal • National Center for Programme Management (CNMP), Romania • The Swedish Research Council (SRC)(Vetenskapsrådet), Sweden • The Swedish Governmental Agency for Innovation Systems (VINNOVA ), Sweden • The Scientific and Technological Research Council of Turkey (TUBITAK), Turkey • Science Council of Lithuania (LSC), Lithuania • Economic development, research and innovation Directorate, Veneto region (Italy) • Ministry of the Walloon Region: Operational General Directorate for Economy, Employment, and Research (DGOEER), Walloon Region (Belgium) www.euronanomed.net

  16. Topics • Diagnostics • Targeted drug delivery • Regenerative medicine www.euronanomed.net

  17. Aim of the 1st call for proposals • To find new medical solutions • To enable an effective multi-national collaboration on research projects • Promoting multidisciplinary efforts • Encouraging translational research proposals that combine either basic/clinical and/or industrial approach • Having an added value in funding the transnational collaboration over the individual projects • To support novel, ambitious ideas and possibility of application to end users www.euronanomed.net

  18. Eligibility criteria Consortia with room for flexibility • 3 -7 partners from at least three partnering countries • At least one clinical/public health research team and/or one industrial research team per consortium • At least two categories (academic/clinical/industrial teams) • Project consortium partners´ eligibility depends upon national regulation www.euronanomed.net

  19. Funding, 1st call • Indicative total funding 15-20 M€ • Funding for up to 3 years • Selected projects receive funding directly from their corresponding national/regional funding bodies after meeting their national regulations www.euronanomed.net

  20. Time lines, 1st call • Call opens: May 25th 2009 • Call closes: September 1st 2009 • Funding decision: December 2009 www.euronanomed.net

  21. For more information • EuroNanoMed Call office Veneto Nanotech s.c.p.a.Via San Crispino, 10635129 Padova – Italy   : +39 049 7705520 email: calloffice@euronanomed.net website: www.euronanomed.net • National/regional contacts www.euronanomed.net

  22. The EuroNanoMed Electronic Submission System • Read carefullyThe Guidelines for Applicants* and contact your National / Regional Contact Point (info + national applicable rules) • Register by clicking on the link ”to register” on the homepage http://www.euronanomed.net/*; you will receive an email confirming your registration • Accede to the  EuroNanoMed Electronic Submission System* (Use the username and password you chose for the registration) fill in all the details and upload your proposal document (pdf format only), which you have previously filled in on your computer (see The Proposal Template)*. • Submit your proposal : Click on “submit proposal” to confirm your submission; you will receive an email confirming its receipt. • Deadline is 01 September 2009 at 17:00:00 (Brussels local time)  Modify your data at any time until the submission deadline. It is strongly recommended to transfer the final version in proper time before this date www.euronanomed.net

  23. In case of Problem… Please contact:  • The EuroNanoMed Call Office • Monday to Thursday 9:00-13:00 and 14:30-18:00, • Friday 9:00-13:00 and 14:30-17:00 (Brussels local time)  : +39 049 7705520 - Fax. +39 049 770555 email: calloffice@euronanomed.net • or your National/Regional Agencycontact point. www.euronanomed.net

  24. Together we are building Nanomedicine for the future! www.euronanomed.net

More Related